Equillium management to participate in upcoming investor conferences
Equillium said management will participate in upcoming investor conferences, with a listed Cantor Global event referenced in the release.
LA JOLLA, Calif., Sept.
02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc.
NASDAQ:EQ, a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:Cantor Global H…